Catalyst Event
Tempus AI Inc (TEM) · Other
From Akros U.S. AI Software TOP4 Plus Index (AUAIS4P)
4/15/2026, 12:00:00 AM
On April 15, 2026, Tempus announced a collaboration with Predicta Biosciences to launch GenoPredicta, a whole-genome sequencing assay for hematologic cancers and measurable residual disease (MRD) monitoring.
Korean Translation
2026년 4월 15일, Tempus는 Predicta Biosciences와의 협력을 통해 혈액암 및 측정 가능한 잔존 질환(MRD) 모니터링을 위한 전체 유전체 시퀀싱 분석법인 GenoPredicta를 출시한다고 발표함.
Related Recent Events
Innodata Inc (INOD) · Earnings Release
First quarter 2026 earnings results and conference call, with a market reaction of at least 5% possible based on previous volatility, scheduled.
5/7/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
First quarter 2026 financial results are scheduled to be released after the U.S. market closes. High importance is estimated due to historical price impact of earnings, scheduled
5/6/2026, 12:00:00 AM
Fastly Inc (FSLY) · Earnings Release
Fastly Q1 2026 earnings release scheduled. High importance as earnings reports for volatile tech stocks often lead to significant price movements.
5/6/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
Tempus AI is expected to release its Q1 2026 earnings on May 5, 2026. Analysts forecast an EPS of -$0.21 to -$0.30, with the market pricing in a potential post-earnings stock price move of over 15% scheduled.
5/5/2026, 12:00:00 AM
Palantir Technologies Inc (PLTR) · Earnings Release
Palantir announced on April 13, 2026, that its first-quarter 2026 financial results will be released on May 4, 2026. This announcement is estimated to cause a price impact of at least 5%, scheduled.
5/4/2026, 12:00:00 AM
ServiceNow Inc (NOW) · Earnings Release
ServiceNow is scheduled to release its financial results for the first quarter of 2026 after the market closes on April 22, 2026; high importance is estimated due to the significant price impact typically associated with quarterly earnings, scheduled.
4/22/2026, 12:00:00 AM